Fine specificity of serum antibodies to Plasmodium falciparum merozoite surface protein, PfMSP-1(19), predicts protection from malaria infection and high-density parasitemia.
D000293:Adolescent; D000818:Animals; D000911:Antibodies, Monoclonal; D000913:Antibodies, Protozoan / Q000097:blood*; D000918:Antibody Specificity; D000953:Antigens, Protozoan / Q000235:genetics; D001667:Binding, Competitive; D002648:Child; D002675:Child, Preschool; D015331:Cohort Studies; D005714:Gambia / Q000453:epidemiology; D006801:Humans; D066298:In Vitro Techniques; D016778:Malaria, Falciparum / Q000453:epidemiology / Q000276:immunology* / Q000469:parasitology; D020066:Merozoite Surface Protein 1 / Q000235:genetics / Q000276:immunology*; D051379:Mice; D009154:Mutation; D018512:Parasitemia / Q000453:epidemiology / Q000276:immunology / Q000469:parasitology; D010963:Plasmodium falciparum / Q000235:genetics / Q000276:immunology*; D021122:Protein Subunits / Q000235:genetics / Q000276:immunology*; D015800:Protozoan Proteins / Q000235:genetics / Q000276:immunology*; D011994:Recombinant Proteins / Q000235:genetics / Q000276:immunology; D016036:Seroepidemiologic Studies; D014454:Uganda / Q000453:epidemiology
D000911:Antibodies, Monoclonal; D000913:Antibodies, Protozoan; D000953:Antigens, Protozoan; D020066:Merozoite Surface Protein 1; D021122:Protein Subunits; D015800:Protozoan Proteins; D011994:Recombinant Proteins